LUXTREON
Dead / Abandoned — Abandoned — after inter partes decision (as of 09 Oct 2019)
What this means for you
This application is over — abandoned 09 Oct 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88062546
- Mark type
- Stylized text
- Filed
- 02 Aug 2018
- Published for opposition
- 11 Jun 2019
- Abandoned
- 09 Oct 2019
- Attorney of record
- Louis C. Cullman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of inflammation and pain; pharmaceutical preparations and substances for the relief of signs and symptoms of dry eye disease; pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; injectable ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations for post-surgical treatment of the eye; topical ophthalmic pharmaceutical preparations for the treatment of dryness of the eye
Owner
- Kala Pharmaceuticals, Inc., Watertown, MA, US
- Kala Pharmaceuticals, Inc., Watertown, MA, US
Prosecution history
- 19 May 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 09 Oct 2019 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 09 Oct 2019 — ABANDONMENT - AFTER INTER PARTES DECISION
- 09 Oct 2019 — OPPOSITION TERMINATED NO. 999999
- 09 Oct 2019 — OPPOSITION SUSTAINED NO. 999999
- 11 Jul 2019 — OPPOSITION INSTITUTED NO. 999999
- 11 Jul 2019 — OPPOSITION PAPERS RECEIVED AT TTAB
- 11 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jun 2019 — PUBLISHED FOR OPPOSITION
- 22 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2019 — ASSIGNED TO LIE
- 23 Apr 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Apr 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED